Learn how olive oil's anti-inflammatory components helped create a less painful and longer lasting mRNA vaccine, and showed ...

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...

In Nature Communications, authors describe a novel web platform for genomic surveillance of the SARS-CoV-2 virus called ...

COVID-19 cases are rising in half of U.S. states. What to know about COVID trends and the new Stratus and Nimbus variants.

In January, a new COVID-19 variant known as NB.1.8.1 was first detected in China. As of mid-May, the variant had reached 10.7% of global reported COVID-19 cases, according to the World Health ...

As a new COVID-19 variant takes over in the U.S., ... Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems.

A new COVID-19 variant named "Nimbus" has been detected in the U.S. and is spreading rapidly. Here's what to know about symptoms and vaccines.

A new study from UCLA Health suggests COVID-19 vaccines may protect patients from severe kidney damage. The study found hospitalized COVID-19 patients were less likely to have severe kidney damage if ...